Understand the source comparison
GLOW Stack vs Traditional Research Compound Cycling
'On' Duration 8–12 weeks continuous dosing 8 weeks full stack + 2 weeks longevity peptides only Shorter 'on' period prevents receptor saturation from stacked agonists 'Off' Duration 2–4 weeks (matches compound half-life × 5) 4–6 weeks complete washout Extended
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 'On' Duration
- 8–12 weeks continuous dosing
- 8 weeks full stack + 2 weeks longevity peptides only
- Shorter 'on' period prevents receptor saturation from stacked agonists
- 'Off' Duration
- 2–4 weeks (matches compound half-life × 5)
- 4–6 weeks complete washout
- Extended recovery required for GH secretagogue receptor density restoration
- Receptor Recovery Monitoring
- Not typically tracked
- IGF-1 baseline measurement pre-cycle and post-washout
- Quantitative biomarker confirms receptor function restoration
- Cessation Protocol
- Immediate stop all compounds
- Staggered: stop secretagogues first, maintain longevity peptides 2 weeks, then full stop
- Prevents rebound effects while preserving mitochondrial adaptations
- Cycles Per Year
- 3–4 (assumes 4-week washout)
- 2 (assumes 6-week washout)
- Fewer cycles with full recovery outperform frequent cycles with diminished response
- Re-sensitisation Evidence
- Subjective (strength, recovery, appearance)
- Objective (pre-cycle IGF-1 within 10% of natural baseline)
- Receptor recovery can be verified through serum IGF-1 testing before restarting